Denmark· DK-28107030023
Dalacin C
A clindamycin product containing clindamycinphosphat, registered in Denmark by Orifarm A/S. The same ATC class is registered in 14 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Clindamycin is registered in 14 of 19 countries.
Countries holding a registration under ATC G01AA10 (clindamycin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Clindamycin · ATC G01AA10
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of clindamycin costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Clindamycin · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- US United States$0.063 (acquisition cost)
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- CLINDAMYCINPHOSPHAT
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- G01AA10
- ATC class
- Clindamycin
- Defined daily dose
- 0.1 g, V
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107030023
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
10 interactions on record for clindamycin.
Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clindamycin · interactions on record
10 records
- 10 moderate
Most severe, free to view
- TubocurarineM03AA02moderate
- SuxamethoniumM03AB01moderate
- PancuroniumM03AC01moderate
- VecuroniumM03AC03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G01AA10
Clindamycin, as other registers publish it.
- United StatesCleocinPharmacia & Upjohn Company LLC
- United StatesCleocinPharmacia & Upjohn Company LLC
- United StatesClindacin PMedimetriks Pharmaceuticals, Inc.
- GermanyClindafanalDr. Pfleger Arzneimittel Gmbh
- ItalyCLINDAMICINA FOSFATO*5 fiale 600 mg 4 mlHIKMA ITALIA SpA
- DenmarkClindamycin "2care4"2care4 ApS
- DenmarkClindamycin "Terix"Terix Labs Limited
- United KingdomClindamycin 2% vaginal creamPfizer Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c8da5d20-f07d-4065-9cbc-4f22dbf5e67e GET /v1/drugs/c8da5d20-f07d-4065-9cbc-4f22dbf5e67e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "vaginalcreme",
"source": "dkma",
"strength": "20 mg/g",
"auth_role": "DKMA",
"dk_drugid": "28107030023",
"substance": "CLINDAMYCINPHOSPHAT",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "45509"
}See everything about clindamycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.